Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
AstraZeneca
Baxter
McKesson
Mallinckrodt

Last Updated: January 18, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for ADX-71149


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug ADX-71149?

ADX-71149 is an investigational drug.

There have been 12 clinical trials for ADX-71149. The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2019.

The most common disease conditions in clinical trials are Sleepiness, Narcolepsy, and Disorders of Excessive Somnolence. The leading clinical trial sponsors are Aldeyra Therapeutics, Inc., Jazz Pharmaceuticals, and Q32 Bio Inc.

There are two US patents protecting this investigational drug and forty international patents.

Recent Clinical Trials for ADX-71149
TitleSponsorPhase
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque PsoriasisAldeyra Therapeutics, Inc.Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.Aldeyra Therapeutics, Inc.Phase 2
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)Aldeyra Therapeutics, Inc.Phase 2

See all ADX-71149 clinical trials

Clinical Trial Summary for ADX-71149

Top disease conditions for ADX-71149
Top clinical trial sponsors for ADX-71149

See all ADX-71149 clinical trials

US Patents for ADX-71149

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ADX-71149 ⤷  Sign up for a Free Trial 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4'] bipyridinyl-2'-ones Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH) ⤷  Sign up for a Free Trial
ADX-71149 ⤷  Sign up for a Free Trial 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2- '-ones Janssen Pharmaceuticals, Inc. (Titusville, NJ) Addex Pharma SA (Geneva, CH) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ADX-71149

Drugname Country Document Number Estimated Expiration Related US Patent
ADX-71149 Argentina AR068511 2027-09-14 ⤷  Sign up for a Free Trial
ADX-71149 Austria AT496906 2027-09-14 ⤷  Sign up for a Free Trial
ADX-71149 Australia AU2008297878 2027-09-14 ⤷  Sign up for a Free Trial
ADX-71149 Brazil BRPI0816767 2027-09-14 ⤷  Sign up for a Free Trial
ADX-71149 Canada CA2696948 2027-09-14 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
AstraZeneca
Baxter
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.